淀粉样变性:多系统疾病谱的影像表现与病理对照
本文综述淀粉样变性的多系统影像表现,涵盖系统性及局限性病变的器官受累特点。MRI和核医学的进展提高了中枢神经系统和心脏淀粉样变性的诊断特异性,心脏MRI联合骨显像在无浆细胞异常患者中可诊断转甲状腺素蛋白淀粉样变性。组织学以刚果红染色及偏振光下苹果绿双折射为特征,影像上软组织浸润和钙化为共同模式,新型靶向治疗凸显早期诊断的重要性。
要点
- 心脏MRI联合骨显像在无浆细胞异常患者中可无创诊断转甲状腺素蛋白心脏淀粉样变性。
- 局限性淀粉样变性常累及皮肤、气管支气管树和泌尿道,影像上可模仿恶性肿瘤。
- 影像共同模式包括软组织浸润和钙化,需结合临床背景提示淀粉样变性诊断。
关键影像表现/征象
- 局限性淀粉样变性最常累及皮肤、气管支气管树和泌尿道,影像上可模仿多种病变包括恶性肿瘤。
- 影像特征因器官系统而异,但共享软组织浸润和钙化等共同模式。
- 组织学上淀粉样物质刚果红染色阳性,偏振光显微镜下呈特征性苹果绿双折射。
诊断标准与关键数值
- 无潜在浆细胞异常患者中,特征性心脏MRI表现联合骨显像可诊断转甲状腺素蛋白心脏淀粉样变性。
- 组织学诊断标准为刚果红染色阳性及偏振光下苹果绿双折射。
临床应用与阅片要点
- 在合适临床背景下,软组织浸润和钙化等共同影像模式可提示淀粉样变性诊断。
- 局限性淀粉样变性影像上可模仿恶性肿瘤,常需组织采样确诊。
- 无浆细胞异常患者中,心脏MRI联合骨显像可无创诊断转甲状腺素蛋白心脏淀粉样变性,特定情况下可避免受累器官活检。
局限性
- 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Amyloidosis is a group of conditions defined by extracellular deposition of insoluble proteins that can lead to multiorgan dysfunction and failure. The systemic form of the disease is often associated with a plasma cell dyscrasia but may also occur in the setting of chronic inflammation, long-term dialysis, malignancy, or multiple hereditary conditions. Localized forms of the disease most often involve the skin, tracheobronchial tree, and urinary tract and typically require tissue sampling for diagnosis, as they may mimic many conditions including malignancy at imaging alone. Advancements in MRI and nuclear medicine have provided greater specificity for the diagnosis of amyloidosis involving the central nervous system and heart, potentially obviating the need for biopsy of the affected organ in certain circumstances. Specifically, a combination of characteristic findings at noninvasive cardiac MRI and skeletal scintigraphy in patients without an underlying plasma cell dyscrasia is diagnostic for cardiac transthyretin amyloidosis. Histologically, the presence of amyloid is denoted by staining with Congo red and a characteristic apple green birefringence under polarized light microscopy. The imaging features of amyloid vary across each organ system but share some common patterns, such as soft-tissue infiltration and calcification, that may suggest the diagnosis in the appropriate clinical context. The availability of novel therapeutics that target amyloid protein fibrils such as transthyretin highlights the importance of early diagnosis. Online supplemental material is available for this article. ©RSNA, 2021.
引用
- Sugi MD, Kawashima A, Salomao MA, et al. Amyloidosis: Multisystem Spectrum of Disease with Pathologic Correlation. Radiographics. 2021. PMID: 34357805. doi:10.1148/rg.2021210006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。